"Post-Marketing Evaluation of Short-Term Safety of COMVAX Vaccine: A Report on the First 6 Months."

According to an abstract submitted by the authors to the 15th International Conference on Pharmacoepidemiology, held August 26-29, 1999, in Boston, Massachusetts, "Background: The objective of this study was to evaluate the short-term safety of COMVAX vaccine as assessed by rates of medical events resulting in death, hospitalization, emergency room visits, and outpatient utilization. This is an interim report, presenting data from the first 6 months of a 3-year study. Methods: The population for this report included all infant members of Group Health Cooperative vaccinated with COMVAX from July-December 1997. During this period, 1,573 children received a first dose of...

Want to see the full article?

• Purchase this article for only $3.00